Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 3—March 2016

Treatment of Mycobacterium abscessus Infection

Shannon A. NovosadComments to Author , Susan E. Beekmann, Philip M. Polgreen, Kate Mackey, Kevin L. Winthrop, and M. abscessus Study Team
Author affiliations: Oregon Health and Science University, Portland, Oregon, USA (S.A. Novosad, K. Mackey, K.L. Winthrop); University of Iowa Carver College of Medicine, Iowa City, Iowa, USA (S.E. Beekmann, P.M. Polgreen)

Main Article

Table 2

Side effects associated with antimicrobial drug therapy for Mycoobacterium abscessus infection, March–December 2013*

Side effect No. (%)
Gastrointestinal† 23 (41.8)
Skin changes‡ 11 (20.0)
Renal insufficiency 9 (16.4)
Hearing loss 7 (12.7)
Tinnitus 6 (10.9)
Loss of balance 4 (7.3)
Transaminitis 4 (7.3)
Shortness of breath or airway irritation 3 (5.5)
Neutropenia or thrombocytopenia 2 (3.6)
Other§ 5 (9.1)

*Data for 55 patients; some patients reported the same adverse event >1 time and attributed it to different medications. Here, each adverse event is reported only 1 time.
†Nausea/vomiting, abdominal pain, diarrhea.
‡Rash, pruritis, discoloration.
§Anxiety, failure to thrive, fatigue, oral and genitourinary candidiasis.

Main Article

1Members of the study team are listed at the end of this article.

Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.